<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-PB9TMLQP</identifier><date>2013</date><creator>Ogulin, Darja</creator><relation>documents/doc/P/URN_NBN_SI_doc-PB9TMLQP_001.htm</relation><relation>documents/doc/P/URN_NBN_SI_doc-PB9TMLQP_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PB9TMLQP_001.txt</relation><format format_type="issue">4</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 323-327</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">27313703</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PB9TMLQP</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">biološka zdravila</subject><subject language_type_id="slv">revmatična obolenja</subject><title>Obravnava revmatičnega bolnika ob uvedeni biološki terapiji - klinična primera iz lekarniške prakse</title><title>Rheumatic patients treatment after the introduction of biological therapy - clinical cases in pharmacy practice</title></Record>